Female Hormones Research Articles

Association between per- and polyfluoroalkyl substances and sex hormone levels in males based on human studies

BackgroundPer- and poly-fluoroalkyl substances (PFAS) are ubiquitous chemicals in the environment and our daily lives. Several epidemiological studies have revealed that PFAS exposure is linked to male sex hormone levels; however, the conclusions are inconsistent across studies. Consequently, we performed a meta-analysis to systematically evaluate the association between PFAS exposure and male sex hormones. MethodsThe Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) standards were followed during the meta-analysis. PubMed, Wed of Science, Embase, Cochrane Library, and Ovid databases were used to identify suitable articles before June 2023. The 95% CI and β values were calculated to assess the association between male sex hormone levels and PFAS exposure. Heterogeneity among the included studies was tested using inconsistency statistics (I2). ResultsThe literature search identified 12 published articles that met our search criteria, involving 7506 participants. Our results revealed that perfluorononanoic acid (PFNA) and perfluorooctanoic acid (PFOA) exposures were negatively correlated with testosterone (β = –0.05; 95% CI: –0.09, –0.02, P = 0.003) and (β = –0.04; 95% CI: –0.08, 0.00, P = 0.049), respectively. ConclusionExposure to PFNA and PFOA is negatively correlated with changes in male testosterone levels. This correlation suggests that we need to pay attention in the future to whether they are potential risk factors for male reproductive health.

The impact of matching for reproductive status on the comparison of magnetic spectroscopic measurements of glutamate and gamma-aminobutyric acid + in the medial prefrontal cortex of women with major depression

ObjectivesThe role played by medial prefrontal cortex (MPFC) glutamate (Glu) and gamma-aminobutyric acid (GABA) in the pathophysiology and the treatment of major depression (MD) is increasingly recognized. Although measurements of MPFC GABA and Glu have been shown to be sensitive to physiological fluctuations of female hormones, none of the magnetic resonance spectroscopy (MRS) investigations of MPFC Glu and GABA in MD have controlled for possible bias effect of the reproductive stage of the women included. MethodsMPFC Glu and GABA+ (which include homocarnosine and macromolecules) referenced to creatine and phosphocreatine, were measured via magnetic resonance spectroscopy (MRS) using a 3-Tesla magnet in 24 women with MD and 24 healthy women paired for reproductive status. All participants were unmedicated. ResultsThere were no statistical differences in either MPFC Glu [95 % CI: (−0.025, 0.034)] or MPFC GABA+ [95 % CI: (−0.005, 0.017)] between women with MD and healthy controls. ConclusionsOur investigation does not support abnormalities in measurement of MPFC Glu and GABA in MD women when stringent control for reproductive status is performed. As a result of the inherent limitations of MRS methodology, our results do not preclude glutamatergic and GABAergic dysregulations in the MPFC of women with MD.

Interaction of estradiol and renin-angiotensin system with microRNAs-21 and -29 in renal fibrosis: focus on TGF-β/smad signaling pathway.

Kidney fibrosis is one of the complications of chronic kidney disease (CKD (and contributes to end-stage renal disease which requires dialysis and kidney transplantation. Several signaling pathways such as renin-angiotensin system (RAS), microRNAs (miRNAs) and transforming growth factor-β1 (TGF-β1)/Smad have a prominent role in pathophysiology and progression of renal fibrosis. Activation of classical RAS, the elevation of angiotensin II (Ang II) production and overexpression of AT1R, develop renal fibrosis via TGF-β/Smad pathway. While the non-classical RAS arm, Ang 1-7/AT2R, MasR reveals an anti-fibrotic effect via antagonizing Ang II. This review focused on studies illustrating the interaction of RAS with sexual female hormone estradiol and miRNAs in the progression of renal fibrosis with more emphasis on the TGF-β signaling pathway. MiRNAs, especially miRNA-21 and miRNA-29 showed regulatory effects in renal fibrosis. Also, 17β-estradiol (E2) is a renoprotective hormone that improved renal fibrosis. Beneficial effects of ACE inhibitors and ARBs are reported in the prevention of renal fibrosis in patients. Future studies are also merited to delineate the new therapy strategies such as miRNAs targeting, combination therapy of E2 or HRT, ACEis, and ARBs with miRNAs mimics and antagomirs in CKD to provide a new therapeutic approach for kidney patients.

Surah Al Fatiha Induced Betterment of Menstrual Cycle and Hormonal Levels of PCOS: Evidence from Clinical Trials

Introduction Polycystic ovarian syndrome is an endocrinal disorder comprising multiple signs and symptoms that are associated with hormonal imbalance. The intervention was administered to subjects who were reluctant to go for pharmacological intervention. Methodology The designed study was intended to evaluate the effect of Surah Al Fatiha in combating PCOS pathology. Inclusion of females was from teenage to 45 years of age. Rotterdam criteria were used to diagnose 7 PCOS cases, while 7 healthy controls were recruited from the Mamji Hospital in Karachi's gynecology department. Surah Al Fatiha exposure was given to all the subjects. Exposure commenced on second day of subject’s menstrual cycle (three times daily) till the subsequent menstrual cycle started. Surah Al Fatiha, a pre-recorded version by ‘Qari Mishary Rashid Alafasy’ was used in this study. Biochemical parameters were monitored and evaluated before and after the Surah Al Fatiha therapy. Results revealed significantly decreased levels of hormones in PCOS afflicted females after Surah Al Fatiha exposure. Insulin and TSH were restored to their normal levels while rest of the hormones though decreased but were in normal range prior to the exposure of intervention. Conclusion Surah Al Fatiha exposure induces serenity and reduces stress, thus inducing normalization of TSH, decreased IR and in turn regularizing the menstrual cycle.

The impact of age-specific childhood body-mass index on adult cardiometabolic traits: a Mendelian randomization study.

To evaluate the causal relationship between childhood body-mass index (BMI) at different ages and adult cardiometabolic traits. We retrieved genetic instrument variables (IVs) for exposures (standardized BMI at newborn, infant, toddler and late childhood), cardiometabolic traits and potential confounders or mediators (adult BMI, SHBG, testosterone and age at menarche) from the corresponding genome-wide association analysis. We performed univariate and multivariable Mendelian randomization (MR) to dissect associations between age-specific childhood BMI and adult cardiometabolic outcomes. Odds ratio was used to present the direction of the causal association. In univariate MR, higher newborn BMI was causally associated with reduced risk for type 2 diabetes in women. Late childhood BMI was associated with increased risk for female diabetes and coronary artery disease (CAD), myocardial infarction (MI), and chronic kidney disease (CKD) in general population. Among these associations, only association between late childhood BMI with MI remained significant after adjusting for adult male BMI and sex hormones, (OR = 1.120, 95% CI 1.023-1.226, p = 0.014). Besides, in multivariable MR, we found evidence for causal association between newborn BMI with reduced risk for CAD (OR = 0.862, 95% CI 0.751-0.989, p = 0.034) and MI (OR = 0.864, 95% CI 0.752-0.991, p = 0.037) in men. No obvious impact of infant or toddler BMI was identified on the above-mentioned diseases. For continuous cardiometabolic traits, in all age epochs except infant, higher BMI was associated with increased level of fasting glucose in women. BMI at birth and late childhood exerts different impact on adult cardiometabolic diseases, while BMI at infant and toddler ages is not causally associated with these outcomes. The effect of childhood BMI may be influenced by sex disparities.

Typological changes in the level of dopamine, cortisol and thyroid hormones in males of Arkhangelsk in the dynamics of year photoperiods

The aim of the study was to consider typological photoperiodic changes in the levels of dopamine, cortisol and thyroid hormones in males of Arkhangelsk.Material and methods. The study sample included 20 young euthyroid males aged 25–44 years, permanently residing in Arkhangelsk. To study the influence of the photoperiodic factor on the functioning of the endocrine system, four months were selected, which are distinguished by the clearest contrast of daylight hours: March (increased daylight hours), June (maximum daylight hours), September (reduced daylight hours) and December (minimum daylight hours). The concentration of dopamine was determined in the blood plasma, and the indicators of the thyroid profile and cortisol level were studied in the serum.Results. Analysis of the data obtained revealed two types of reactions from the dopaminergic system and cortisol content during the period of minimal daylight hours. Along with the seasonal dynamics of dopamine, there is a change in the activity of the pituitary-thyroid system.Conclusions. In males, whose dopamine levels increase from September to December, the concentrations of cortisol and thyroid hormones also increase, that is, several stress systems are simultaneously activated – the adrenal medulla and cortex, the thyroid gland. Thus, there is a more pronounced reaction to the appearance of seasonal stress factors, which may be due to the rather successful adaptation of the respondents to the environment and may indicate that respondents with dopamine levels decreasing or not changing from September to December either have reduced reserve capacity of the body, or hormones are more actively spent on metabolic processes.

Aromatase Inhibitors as a Promising Direction for the Search for New Anticancer Drugs.

Aromatase is an enzyme that plays a crucial role in the biosynthesis of estrogens, which are hormones that contribute to the growth of certain types of breast cancer. In particular, aromatase catalyzes the conversion of androgens (male hormones) into estrogens (female hormones) in various tissues, including the adrenal glands, ovaries, and adipose tissue. Given the role of estrogen in promoting the growth of hormone-receptor-positive breast cancers, aromatase has become an important molecular target for the development of anticancer agents. Aromatase inhibitors can be classified into two main groups based on their chemical structure: steroidal and non-steroidal inhibitors. This work presents a review of the literature from the last ten years regarding the search for new aromatase inhibitors. We present the directions of search, taking into account the impact of structure modifications on anticancer activity.

Steroid Use: What Teens Need to Know

Patient Education| 2021 Steroids: Play Safe, Play Fair Connected Content Translation: Los esteroides: Juega a lo seguro, juega limpio: (Steroids: Play safe, play fair) Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Share Icon Share Facebook Twitter LinkedIn Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Steroids: Play Safe, Play Fair. Pediatric Patient Education 2021; 10.1542/peo_document095 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search nav search search input Search input auto suggest search filter All AAP SitesAll PublicationsPediatric Patient Education Search Advanced Search Topics: athlete, steroids The best athletes rely on practice and hard work to help them do their best. How about you? Ever tempted to use steroids? Well, keep this in mind—not only is it illegal, dishonest, and unfair, but you will be putting your health at risk! You may have heard steroids called roids, juice, hype, or pump. Anabolic-androgenic steroids are powerful prescription drugs that some athletes use not for medical reasons, but as a way to boost athletic performance and build muscle and body mass. They work by acting like the body's natural male hormone, testosterone. Don't confuse them with corticosteroids, which are a different type of steroid used to treat diseases like asthma, arthritis, and many other medical conditions. Remember, steroids might give you bigger muscles, but they cannot improve talent or skill. Athletic ability comes from a combination of things like... Copyright © 2007 American Academy of Pediatrics, Updated 2/07 You do not currently have access to this content.

Association between exposure to polycyclic aromatic hydrocarbons and endometriosis: data from the NHANES 2001-2006.

To evaluate the association between urinary polycyclic aromatic hydrocarbon (PAH) metabolites and the risk of endometriosis. This cross-sectional study obtained data on women aged 20-54 years from the National Health and Nutrition Examination Survey (NHANES) 2001-2006. The weighted multivariate logistic regression model was established to assess the association between the eight urinary PAH metabolites and the risk of endometriosis. In this multivariate analysis, the eight urinary PAH metabolites were adjusted with urinary creatinine, and were divided into three groups according to tertiles: Tertile 1, Tertile 2 and Tertile 3. To evaluate the overall association of mixed PAH metabolites with endometriosis, the Bayesian kernel machine regression (BKMR) model was applied. Totally 1,291 women were included, of which 90 (6.97%) had endometriosis and 1,201 (93.03%) did not have endometriosis. After adjusting for age, race, smoking, age at menarche, hysterectomy, ovary removed, female hormone use, and menopause, compared with the Tertile 1 group, the Tertile 2 and Tertile 3 groups of all PAH metabolites demonstrated no significant risk of endometriosis. A positive tendency was found between mixed PAH metabolites and endometriosis when all the metabolites were at their 60th percentile levels or above compared with their median levels. When all the other metabolites were fixed at their median levels, 1-hydroxynaphthalene was positively correlated with endometriosis. Potential interactions existed between 1-hydroxynaphthalene and 2-hydroxynaphthalene and between 2-hydroxyfluorene and 3-hydroxyfluorene. No significant association was found between individual PAH metabolites and endometriosis. A positive association existed between mixed PAH metabolites and the risk of endometriosis.

Role of female reproductive hormones and genetics in temporomandibular joint disorders.

The disorders of temporomandibular joint manifest clinically with disruptions in its movement and facial pain. Women exhibit athree-fold higher propensity for developing temporomandibular joint disorders compared to men. There are several studies describing the effects of female reproductive hormones on temporomandibular joint structures and pain perception, shedding light on the genetic influence underlying these conditions. Several polymorphisms have been studied and documented in the literature, shedding light on the genetic background of temporomandibular joint disorders.This review aims to propose anovel approach to the complex diagnosis and treatment of this type of disorders. Specifically, we advocate for heightening the emphasis on young women diagnosed with temporomandibular joint disorders during their reproductive years, as such manifestation could potentially serve as early indicators of other underlying health conditions linked to the reproductive system. We posit that genetic studies hold promise as acornerstone for tailoring personalized treatment strategies for TMJD in the future (Tab. 1, Ref. 46). Text in PDF www.elis.sk Keywords: temporomandibular joint disorders, infertility, female reproductive hormones, genetic polymorphism.

The usefulness of peri-trigger female reproductive hormones (delta-FRH) in predicting oocyte maturation in normal ovarian reserve patients who received in vitro fertilization-embryo transfer: a retrospective study.

To evaluate the efficacy of peri-trigger female reproductive hormones (FRHs) in the prediction of oocyte maturation in normal ovarian reserve patients during the in vitro fertilization-embryo transfer (IVF-ET) procedure. A hospital database was used to extract data on IVF-ET cases from January 2020 to September 2021. The levels of female reproductive hormones, including estradiol (E2), luteinizing hormone (LH), progesterone (P), and follicle-stimulating hormone (FSH), were initially evaluated at baseline, the day of the trigger, the day after the trigger, and the day of oocyte retrieval. The relative change in E2, LH, P, FSH between time point 1 (the day of trigger and baseline) and time point 2 (the day after the trigger and day on the trigger) was defined as E2_RoV1/2, LH_RoV1/2, P_RoV1/2, and FSH_RoV1/2, respectively. Univariable and multivariable regression were performed to screen the peri-trigger FRHs for the prediction of oocyte maturation. A total of 118 patients were enrolled in our study. Univariable analysis revealed significant associations between E2_RoV1 and the rate of MII oocytes in the GnRH-agonist protocol group (p<0.05), but not in the GnRH-antagonist protocol group. Conversely, P_RoV2 emerged as a potential predictor for the rate of MII oocytes in both protocol groups (p<0.05). Multivariable analysis confirmed the significance of P_RoV2 in predicting oocyte maturation rate in both groups (p<0.05), while the association of E2_RoV1 was not significant in either group. However, within the subgroup of high P_RoV2 in the GnRH-agonist protocol group, association was not observed to be significant. The C-index was 0.83 (95% CI [0.73-0.92]) for the GnRH-agonist protocol group and 0.77 (95% CI [0.63-0.90]) for the GnRH-antagonist protocol group. The ROC curve analysis further supported the satisfactory performance of the models, with area under the curve (AUC) values of 0.79 for the GnRH-agonist protocol group and 0.81 for the GnRH-antagonist protocol group. P_RoV2 showed significant predictive value for oocyte maturation in both GnRH-agonist and GnRH-antagonist protocol groups, which enhances the understanding of evaluating oocyte maturation and inform individualized treatment protocols in controlled ovarian hyperstimulation during IVF-ET for normal ovarian reserve patients.

Documented associations between selected trace metals, obesity, and reproductive hormones in females: Need for future research

Documented associations between selected trace metals, obesity, and reproductive hormones in females: Need for future research

Overlapping action of melatonin and female reproductive hormones-Understand the impact in pregnancy and menopause.

Melatonin is an indolamine secreted to circulation by the pineal gland according to a circadian rhythm. Melatonin levels are higher during nighttime, and the principal function of this hormone is to organize the temporal night and day distribution of physiological adaptive processes. Besides hormonal pineal production, melatonin is synthesized in various organs and tissues like the ovaries or the placenta for local utilization. In addition to its function as a circadian messenger, melatonin is also associated with many physiological functions. For example, melatonin has antioxidant properties and is involved in the regulation of energy and bone metabolism, and reproduction. Melatonin impacts several stages of reproduction and the action across the hypothalamus-pituitary-gonadal axis is well described. However, it is not well understood how those actions impact the female reproductive hormones secretion nor the consequent physiological outcomes. Thus, the first part of this chapter describes the regulation of female reproductive hormone synthesis by melatonin. Moreover, melatonin and female reproductive hormones have coincident physiological functions. Life stages like pregnancy or menopause are characterized by alterations in the reproductive hormones secretion that may be associated with certain physiological stages. Therefore, the second part discusses whether melatonin fluctuations could have an overlapping role with reproductive hormones in contributing to clinical outcomes associated with pregnancy and menopause.

Clinical effect of equol supplementation in the treatment of desquamative gingivitis with 1-year follow-up.

Desquamative gingivitis (DG) is characterized by desquamative erosion, edematous erythema, and vesicle formation on the gingiva. Because of its prevalence in women during the pre- and postmenopausal period, its potential association with female hormones has been suggested. Equol is a soy isoflavone metabolite with a chemical structure similar to estrogen. Scientific evidence suggests that equol helps in alleviating menopausal symptoms. This study evaluated the clinical effect of a 12-month equol supplementation as a substitute for estrogen to alleviate DG symptoms. The study enrolled 16 women with DG who regularly visited Nihon University School of Dentistry Dental Hospital. Urinary equol levels, periodontal tissue examination, O'Leary's plaque control record, stimulated saliva flow rate, and gingival pain-related questionnaires were evaluated before and after the 12-month daily intake of 10 mg equol supplement. Equol supplementation led to a statistically significant improvement in bleeding on probing, visual findings, and reductions in the frequency and severity of gingival pain. Urinary equol testing and equol supplementation may be novel treatment options for female patients with DG.

Modificări gingivale în sarcină-manifestări clinice și recomandări practice

Fluctuations in female hormones have a complex infl uence on gum health. Pregnancy greatly infl uences the health of the whole body, including the gingival tissues, and correlates with a high degree of carious and gingival damage. Performing regular dental check-ups to keep plaque under control, along with maintaining personalized hygiene at home, can lessen the impact and risks of hormonal fl uctuations on the gums.

Qingre Jiangni formula improves esophageal epithelial barrier function in gastroesophageal reflux rats through male hormones and the p38/MAPK pathway

Qingre Jiangni formula improves esophageal epithelial barrier function in gastroesophageal reflux rats through male hormones and the p38/MAPK pathway

Estrogen receptors, hormonal imbalance, gynecomastia, hyperestrogenemia, and male breast cancer: a literature review

Male breast cancer (MBC) is a rare, malignant tumor. It occurs in men where it accounts for less than 1% of all breast cancers. This is linked with the hormonal imbalance of estrogen and androgen levels. The objective of this review is to provide the details about pathophysiology of gynecomastia (GM) caused by estrogen hormone imbalance along with the explanation of hyperestrogenemia caused by excessive estrogen, the treatment, the adjuvant, and preventive management of MBC currently used by clinical research. Treatment, prevention, and management strategies for MBC follow the similar protocols as for female breast cancer, but today’s treatment strategies include hormone-manipulating chemotherapy and biologics. The use of gene metabolites or active isomers, hormonal therapy and resection are also illustrated in clinical cases. Regarding the treatment and prevention of MBC, it is expected that the treatment strategies will shift to personalized medicine in the future, as it is difficult to identify mutant genes and perform effective genetic screening. Nevertheless, through our narrative review, this article discusses the differences between male and female breast cancer, the relationship between male hormones and breast cancer, and potential future treatment strategies.

Establishment of Reference Interval of Thyroid Hormones and Autoantibodies: A Cross-sectional Study

Introduction: The accurate diagnosis of thyroid disease relies on the sensitivity and specificity of laboratory tests, which require specific reference intervals. Thyroid hormone levels can be influenced by factors such as age, gender, iodine intake and geographical region. Therefore, it is recommended for clinical laboratories to establish their own reference intervals. Aim: To establish reference intervals for Thyroid Stimulating Hormone (TSH), Free Thyroxine (FT4), Anti-thyroglobulin antibody (anti-TG), and Anti-Thyroid Peroxidase Antibody (antiTPO) in males and and females. Materials and Methods: A cross-sectional study was conducted in the Department of Biochemistry, Amrita Institute of Medical Sciences (AIMS), Kochi, India, from December 2021 to July 2022. The study included 217 apparently healthy subjects aged between 18 years and 60 years. TSH, FT4, anti-TPO, and anti-TG levels were analysed to establish reference values for males and females in the two age groups: 18-40 years and 41-60 years. Reference intervals for thyroid parameters were expressed as mean±Standard Deviation (SD), median, 2.5th and 97.5th percentiles. The Mann-Whitney U test was used to assess the statistical significance of thyroid parameters between gender and age groups. Results: The mean age in the female population was 38.24±11.64 years, while in the male population, it was 39.24±10.98 years. The reference intervals and cut-offs for TSH, FT4, anti-TG and anti-TPO in females were determined as 0.80-4.12 μIU/mL, 0.99- 1.57 ngm/mL, &lt;85.33 IU/mL and &lt;45.13 IU/mL, respectively. In males, the reference intervals and cut-offs for TSH, FT4, anti-TG and anti-TPO were determined as 0.51-5.09 μIU/mL, 1.03-1.79 ng/mL, &lt;87.09 IU/mL and &lt;33.88 IU/mL, respectively. There was a significant difference in anti-TPO (p-value=0.017) in males between the two age groups. A significant difference was also observed in FT4 (p-value=0.010) and anti-TPO (p-value=0.034) between males and females. Conclusion: The study successfully established reference intervals and cut-off values for TSH, FT4, anti-TG, and antiTPO. It was found that anti-TPO levels decrease significantly with age progression. Additionally, the reference interval for TSH was wider in the 41-60 years age group compared to the younger age group.

The application of pheromones extracted from Shami goats' male hair and Awassi sheep male wool during the breeding season on LH and Progesterone concentrations in Awassi ewes in Syria.

The efficiency and profitability of animal farming systems are closely linked to the reproductive success of livestock, which requires effective management through biological, hormonal, and nutritional strategies. The "male effect," referring to the influence of male pheromones on female reproductive hormones, offers several benefits. This leads to improved reproductive management, better timing of breeding, and increased fertility rates. Additionally, using natural pheromones provides a non-invasive and sustainable method for managing reproduction, and it can be a cost-effective strategy, reducing the need for expensive hormonal treatments. Incorporating male pheromones into reproductive management practices can thus boost the efficiency and profitability of animal farming systems. The study's objective is to examine the influence of pheromones, extracted from Awassi ram's wool and Shami goat buck's hair, on the secretion of luteinizing hormone (LH) and Progesterone (P4) in Awassi ewes during the breeding season. The pheromones were extracted using a soaking method with dichloromethane as the solvent. The resulting organic extract was then analyzed using a Chromatec-Crystal 5,000 gas chromatography-mass spectrometry device, equipped with a quadrupole mass spectrometer. The experiment was carried out on three equal groups, each consisting of 17 subjects, during the breeding season. In Group I, 15 ml of the ram's wool extract was applied to a piece of gauze and placed in a specially designed mask that was attached directly to the nose. In the second group, a similar procedure was followed using 15 ml of the buck's hair extract. The third group consisted of Awassi rams. The LH assay was conducted immediately before the treatment and again at 1, 10, and 20 hours post-treatment, and after 5 and 30 days of treatment to assess P4 levels. The study found that pheromones from Awassi rams and Shami goat bucks significantly increased the levels of LH and P4 in female Awassi sheep. The study concludes that the pheromones extracted from the wool of rams and Shami goat bucks can stimulate the response of female Awassi sheep. This finding opens up the possibility of using these pheromones in the reproductive management of female Awassi sheep.

Knock-in of a 3’ UTR Stop Cassette into the Wnt4 locus increases mRNA expression and leads to ovarian cyst formation

Wnt4 signaling is critical for mammalian female sex determination, in female reproductive organ development, in follicular and oocyte maturation, and in steroid hormone production. When Wnt4 function is impaired, female embryos undergo partial female to male sex-reversal. This phenotype is associated with the expression of a set of somatic genes that are typical for the male differentiation pathways such as those of the Leydig cells. Given the roles of the 3`untranslated region (3`UTR) in control of gene expression, we addressed whether a knock-in of a stop cassette to 3`END of the Wnt4 gene would impact female reproductive system development or function. The 3`UTRstop cassette indeed affected Wnt4 gene expression in vivo so that the respective mRNA was upregulated in the ovaries of a three month-old female. The homozygous Wnt4 3`UTRstop mice were noted to be leaner than their wild type (WT) littermate controls. Analysis of the ovarian follicular count at the age of three months revealed increased pre-antral but reduced ovarian corpus luteum follicular counts. Furthermore, two out of five of the homozygous female Wnt4 3`UTRstop mice had ovarian cysts, not noted in WT controls. RT-qPCR and in situ hybridization analysis depicted changes in the expression of a panel of genes which encode enzymes that mediate the synthesis of female steroid hormones or their receptors due to the Wnt4 3`UTRstop knock-in. Thus, female mice which had the homozygous construct exhibited elevated ovarian Wnt4 mRNA expression and the corresponding knock-in was associated with changes in ovarian development and folliculogenesis. Our data reinforce the conclusion that deregulated Wnt4 expression impacts female sex organogenesis, ovary development and function, and that the Wnt4 3`UTRstop knock-in mouse provides a model to explore in more detail the roles of Wnt4 signaling in the process.